Literature DB >> 33995769

Spinocerebellar ataxia Type 7: clinical and genetic study of a new Moroccan family (case report).

Fatima Zahra Bouzid1,2, Maria Mansouri1, Chaikhy Abdelaziz3, Nisrine Louhab2,4, Sablonniere Bernard5, Isabelle Strubi-Vuillaume4, Kenza Dafir1,2, Nisrine Aboussair1,2.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) is a rare autosomal dominant neurodegenerative disease. Its clinical presentation is a progressive cerebellar ataxia associated with cone and retinal dystrophy. The CAG repeat expansion in the ataxin-7 gene (ATXN7) causes spinocerebellar ataxia type 7 - a mutation that results in the degeneration of the brain stem cells, retina and cerebellum. We report in this study the clinical and genetic features of a new Moroccan family of SCA7, from the South of Morocco. We performed the molecular genetic testing to confirm the diagnosis of SCA7. The objective of this study is to report a new Moroccan case of SCA7 and to illustrate the role of the geneticist in the diagnosis, management and development of genetic counseling of SCA7 disease. Copyright: Fatima Zahra Bouzid et al.

Entities:  

Keywords:  ATXN7 gene; CAG repeats; Case report; spinocerebellar ataxia type 7

Mesh:

Substances:

Year:  2021        PMID: 33995769      PMCID: PMC8077635          DOI: 10.11604/pamj.2021.38.162.27262

Source DB:  PubMed          Journal:  Pan Afr Med J


  7 in total

1.  Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.

Authors:  J Martin; N Van Regemorter; J Del-Favero; A Löfgren; C Van Broeckhoven
Journal:  J Neurol Sci       Date:  1999-09-15       Impact factor: 3.181

2.  Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7.

Authors:  M D Kaytor; L A Duvick; P J Skinner; M D Koob; L P Ranum; H T Orr
Journal:  Hum Mol Genet       Date:  1999-09       Impact factor: 6.150

3.  Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).

Authors:  G David; A Dürr; G Stevanin; G Cancel; N Abbas; A Benomar; S Belal; A S Lebre; M Abada-Bendib; D Grid; M Holmberg; M Yahyaoui; F Hentati; T Chkili; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

4.  Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families.

Authors:  T P Enevoldson; M D Sanders; A E Harding
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

5.  Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology.

Authors:  Laura C Horton; Matthew P Frosch; Mark G Vangel; Carol Weigel-DiFranco; Eliot L Berson; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

Review 6.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

7.  Clinical and genetic analysis of spinocerebellar ataxia type 7 (SCA7) in Zambian families.

Authors:  Masharip Atadzhanov; Danielle C Smith; Mwila H Mwaba; Omar K Siddiqi; Alan Bryer; L Jacquie Greenberg
Journal:  Cerebellum Ataxias       Date:  2017-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.